| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +16.67% | +8.22% | +0.67% | +7.55% | +9.06% | — |
| 14d | 6 | +16.67% | +5.99% | -0.12% | +6.11% | +8.39% | — |
| 30d | 6 | +66.67% | -4.37% | -0.95% | -3.42% | -2.39% | — |
| 60d | 6 | +16.67% | +7.37% | +3.44% | +3.92% | +1.89% | — |
| 90d | 6 | +16.67% | +13.71% | +5.54% | +12.63% | +20.49% | — |
| 180d | 6(3 pending) | +0.00% | +21.59% | +10.79% | +10.80% | +3.20% | — |
| 1y | 6(5 pending) | +0.00% | +46.17% | +25.21% | +20.96% | +20.96% | — |
| 2y | 6(6 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ARDX ARDELYX, INC. | SALE Chief Business Officer | 2,478 | $6.27 | $15.5K | 357,418 | May 21, 2026 | May 22, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | SALE Chief Business Officer | 2,900 | $6.27 | $18.2K | 361,766 | May 21, 2026 | May 22, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | SALE Chief Business Officer | 1,870 | $6.27 | $11.7K | 359,896 | May 21, 2026 | May 22, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | SALE See Remarks | 2 | $5.71 | $11 | 364,666 | Feb 20, 2026 | Feb 23, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | SALE See Remarks | 8,434 | $5.87 | $49.5K | 365,827 | Feb 20, 2026 | Feb 23, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | SALE See Remarks | 1,159 | $5.71 | $6.6K | 364,668 | Feb 20, 2026 | Feb 23, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | PURCHASEGRANT Stock grant | 154,625 | — | — | 154,625 | Jan 23, 2026 | Jan 26, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | PURCHASEGRANT Stock grant | 103,080 | — | — | 374,261 | Jan 23, 2026 | Jan 26, 2026 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,500 | — | — | 15,500 | Jan 5, 2026 | Jan 7, 2026 ↗ | View → |
| ARDX ARDELYX, INC. | SALE See Remarks | 5,560 | $5.54 | $30.8K | 271,181 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| ARDX ARDELYX, INC. | SALE Chief Business Officer | 5,417 | $5.93 | $32.1K | 276,741 | Aug 21, 2025 | Aug 28, 2025 ↗ | View → |
| ARDX ARDELYX, INC. | SALE See Remarks | 14,522 | $4.08 | $59.3K | 282,158 | May 20, 2025 | May 22, 2025 ↗ | View → |
| ARDX ARDELYX, INC. | PURCHASEGRANT Stock grant | 136,680 | — | — | 296,680 | Feb 25, 2025 | Feb 27, 2025 ↗ | View → |
| ARDX ARDELYX, INC. | PURCHASEGRANT Stock grant | 205,019 | — | — | 205,019 | Feb 25, 2025 | Feb 27, 2025 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,750 | — | — | 5,750 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,940 | — | — | 11,940 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,440 | — | — | 1,440 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| ARDX ARDELYX, INC. | PURCHASEGRANT Stock grant | 160,000 | — | — | 160,000 | Mar 25, 2024 | Mar 27, 2024 ↗ | View → |
| ARDX ARDELYX, INC. | PURCHASEGRANT Stock grant | 205,000 | — | — | 205,000 | Mar 25, 2024 | Mar 27, 2024 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,730 | — | — | 4,730 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 890 | — | — | 890 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 29,250 | — | — | 29,250 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| CAPR CAPRICOR THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 115,000 | Sep 1, 2023 | Sep 6, 2023 ↗ | View → |